| Nov 12, 2025 |
Nov 14, 2025 |
PERRIGO Co plc
|
Director |
Buy |
95.0
|
+7,500
|
11.60%
|
✗
|
$106.4K |
| Oct 21, 2025 |
Oct 23, 2025 |
Allogene Therapeutics, Inc.
|
CFO |
Sell |
46.3
|
-36,744
|
-2.80%
|
✗
|
$46.2K |
| Aug 18, 2025 |
Aug 20, 2025 |
PERRIGO Co plc
|
Director |
Buy |
90.0
|
+4,375
|
7.26%
|
✗
|
$100.5K |
| Aug 18, 2025 |
Aug 19, 2025 |
PERRIGO Co plc
|
Director |
Buy |
90.0
|
+4,375
|
7.26%
|
✗
|
$100.5K |
| May 14, 2025 |
May 16, 2025 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-4,754
|
-7.31%
|
✗
|
$123.7K |
| May 12, 2025 |
May 14, 2025 |
PERRIGO Co plc
|
Director |
Buy |
90.0
|
+3,500
|
6.78%
|
✗
|
$94.9K |
| Feb 3, 2025 |
Feb 5, 2025 |
Allogene Therapeutics, Inc.
|
CFO |
Sell |
52.5
|
-4,361
|
-0.33%
|
✗
|
$7.5K |
| Oct 21, 2024 |
Oct 23, 2024 |
Allogene Therapeutics, Inc.
|
CFO |
Sell |
42.5
|
-36,404
|
-3.12%
|
✗
|
$103.4K |
| May 15, 2024 |
May 16, 2024 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-4,207
|
-17.19%
|
✗
|
$127.1K |
| Jan 30, 2024 |
Mar 6, 2024 |
Allogene Therapeutics, Inc.
|
CFO |
Buy |
47.5
|
+190
|
0.02%
|
✗
|
$683.1 |
| Jun 13, 2023 |
Jun 14, 2023 |
PERRIGO Co plc
|
Director |
Buy |
97.5
|
+10,000
|
26.97%
|
✗
|
$330.6K |
| May 17, 2023 |
May 19, 2023 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-3,734
|
-9.15%
|
✗
|
$122.7K |
| Mar 6, 2023 |
Mar 7, 2023 |
PERRIGO Co plc
|
Director |
Buy |
95.0
|
+5,000
|
17.83%
|
✗
|
$190.3K |
| May 17, 2022 |
May 19, 2022 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-3,168
|
-10.15%
|
✗
|
$122.2K |
| Dec 16, 2021 |
Dec 17, 2021 |
PERRIGO Co plc
|
Director |
Buy |
95.0
|
+5,000
|
25.50%
|
✗
|
$184.3K |
| May 7, 2021 |
May 11, 2021 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-2,786
|
-12.44%
|
✗
|
$119.7K |
| Mar 17, 2021 |
Mar 18, 2021 |
PERRIGO Co plc
|
Director |
Buy |
95.0
|
+2,500
|
17.74%
|
✗
|
$103.2K |
| May 15, 2020 |
May 19, 2020 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-2,906
|
-17.10%
|
✗
|
$153.3K |
| May 15, 2019 |
May 17, 2019 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-1,907
|
-14.84%
|
✗
|
$94.5K |
| Nov 12, 2018 |
Nov 13, 2018 |
PERRIGO Co plc
|
Director |
Buy |
95.0
|
+3,000
|
51.03%
|
✗
|
$196.1K |
| Jun 6, 2018 |
Jun 8, 2018 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-2,048
|
-25.84%
|
✗
|
$150K |
| Jul 20, 2017 |
Jul 24, 2017 |
PERRIGO Co plc
|
Director |
Sell |
22.5
|
-936
|
-17.51%
|
✗
|
$70.7K |
| Dec 8, 2016 |
Dec 16, 2016 |
Viracta Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+3,740
|
36.19%
|
✗
|
$14.5K |
| Dec 8, 2016 |
Dec 12, 2016 |
Viracta Therapeutics, Inc.
|
Director |
Buy |
86.3
|
+3,740
|
6.03%
|
✗
|
$14.5K |
| Nov 21, 2016 |
Nov 21, 2016 |
PERRIGO Co plc
|
Director |
Buy |
95.0
|
+2,500
|
1666.67%
|
✗
|
$221.9K |
| May 26, 2016 |
May 27, 2016 |
Viracta Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+9,500
|
18.09%
|
✗
|
$4.5K |
| May 24, 2016 |
May 26, 2016 |
Viracta Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+52,505
|
100.00%
|
✗
|
$24.8K |